DOCSLIB.ORG

Informational

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Informational INFORMATIONAL Coronavirus Daily Update TLP:GREEN Aug 19, 2021 This email is provided for informational, non-commercial purposes only. Use or reliance on the information contained in this email is at your sole risk. This email is not provided by or affiliated in any way with Ally Financial Inc. These updates are being shared to multiple organizations, individuals and lists who/which are bcc’d. Best effort we are sending Daily updates during the business week, typically in the evening, a Weekend Recap on Monday mornings, and any significant breaking news events provided anytime. Please note some numbers included in the Statistics and news stories come from various sources and so can vary as they are constantly changing and not reported at the same time. All communications are TLP GREEN and can be shared freely. Know someone who might want to be added to our Updates? Of course ask them first, and then have them send us an email to [email protected]. Greetings, the following are the major Headlines, “Good Stuff”, US Snapshots, US Vaccinations, US Variant Proportions, Highlights, as well as key Statistics, US State Variants, Vaccine and Treatment information, US Restrictions and the Back to Normal Index related to the novel coronavirus pandemic. Today, some inspiration words of optimism from an unknown author, who said: When you look at a field of dandelions, you can either see a hundred weeds, or a thousand wishes. Perspective. Attitude. Point of view. So often, it really is all about how we look at things. Seeing what is in front of us. What we are facing. And of course it is a lot easier to see the good when things are going well. And just as easy to see the bad when we are facing challenges and adversity. And that’s ok. It’s what makes us human. It’s just about doing our best, whenever we can, to look for the positive. To realize that storm clouds will pass to let the sun shine again. That darkness brings out the beauty of the stars. But the real key is remembering and recognizing the gifts we have. Especially when we are struggling and it’s easy to forget them. Letting them help us see the beauty and hope in that field of dandelions. And finding the joy and blessings that make our lives and those in it, special. So as often as we can let’s go find those wishes and let them help us see just how grateful we should be ????. CVOB Website Dashboard, individual US State, US County, Global Trending Charts and Data as well as US Restrictions, US Vaccinations, US Variants, our Communications Archive and the COVID-19 Reference page can be found at https://www.sunknighty.net/. SPECIAL – Booster Shots The New York State Department of Health found that vaccines remained 92% to 95% effective at preventing hospitalizations among the vaccinated, but the effectiveness of the vaccines declined from about 92% to 80% in reducing cases, according to the study published today by the Centers for Disease Control and Prevention of people older than 18 from early May to late July that supported the need for booster shots starting this fall. A new Centers for Disease Control and Prevention analysis found that Pfizer and Moderna vaccine efficacy dropped "significantly" among nursing home residents as the Delta variant became the predominant strain in the US, with researchers analyzing weekly reports from thousands of facilities and finding that mRNA vaccines were roughly 75% effective against preventing any infection in late winter/early spring of 2021, early in the mass vaccination rollout and prior to the emergence of the variant, but by summer of this year, effectiveness against any infection had dropped to 53%, supporting the need for boosters announced today. A third dose of Pfizer/BioNTech's COVID-19 vaccine was found to be 86% effective in people aged over 60, an Israeli healthcare provider said on Wednesday, citing initial results from a study of thousands of members. It is "conceivable" that the planned rollout of Covid-19 booster shots could help reduce the spread of disease, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Wednesday, explaining that data shows the third shot prompts the body to produce a new batch of antibodies that catch the virus as it tries to enter the body and could stop the virus from multiplying in the nose and throat after someone breathes it in. The White House's plan to offer coronavirus booster shots to vaccinated adults starting in September still depends on whether the US Food and Drug Administration authorizes boosters and whether the US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommends those boosters, US Surgeon General Dr. Vivek Murthy said Wednesday, adding that "I want to be very clear: We are not skipping the very important FDA and ACIP process here,” and adding “They have an incredibly important role to play in evaluating safety and making recommendations for vaccines.” President Biden appealed directly to vaccinated Americans Wednesday afternoon, reassuring them that they are well protected, but also encouraging them to get their booster shots eight months after their second dose in accordance with the roll out plan his administration announced earlier this morning, adding that "It's the best way to protect ourselves from new variants that could arrive." White House Coronavirus Response Coordinator Jeff Zients said Wednesday that getting a booster shot will be just as easy as getting the first shot, explaining “I want to be clear, the President's whole of government vaccination effort is ready to get every American who needs one a booster shot,” pointing to the more than 80,000 vaccination sites available to Americans across the country, including 40,000 local pharmacies, and pledging, “boosters will be free, regardless of immigration or health insurance status, no ID or insurance required.” President Biden disagreed today with critics who have argued against Americans receiving booster shots while many people in other parts of the world have not yet received their first dose of the vaccine, pointing out the US has donated more vaccine doses than the rest of the world combined while committing to giving away more than 600 million doses, saying “We can take care of America and help the world at the same time,” and that offering the shots does not come at the expense of countries that have struggled to get access to the vaccine. Headlines Covid-19 continues to spread across the US, with nearly 93% of the US population lives in an area with high Covid-19 transmission, according to data from the US Centers for Disease Control and Prevention, and while case rates tend to be higher in less vaccinated states, disparities in hospitalization and death rates are even larger between the least and most vaccinated states, according to federal data. In the week ending Tuesday, 46 of 50 states in the US experienced double-digit growth in covid-19 hospitalizations, according to an analysis by The Washington Post, with eight states, including California and New York, which for most of the summer had not seen many serious cases, adding more than 400 new inpatients in that time. The US reported more than 1,000 COVID-19 deaths on Tuesday, equating to around 42 fatalities an hour, according to a Reuters tally, as the Delta variant continues to ravage parts of the country with low vaccination rates, with coronavirus-related deaths spiking over the past month and averaging 769 per day, the highest since mid-April. The Delta variant of the coronavirus now accounts for 98.8 percent of new infections in the US, according to an estimate from the Centers for Disease Control and Prevention, and in just three months, this highly transmissible variant has outcompeted all other strains of the virus. Mississippi, whose vaccination rate of 36% ranks among the nation's lowest, holds the dubious distinction of reporting the highest number of coronavirus infections per capita, and the state recently opened its second field hospital to treat a surge of coronavirus patients, with 32 beds under tents set up in a garage at the University of Medical Center in Jackson. Two hundred million Americans will have received at least one dose of a Covid-19 vaccine once the vaccination numbers from Wednesday are reported, White House Covid-19 response coordinator Jeff Zients announced, touting the increase in the vaccination rate both broadly, and specifically among adolescents as they return to school, as a milestone with nearly seven million Americans receiving their first dose over the past two weeks. President Biden announced Wednesday afternoon that he is directing the Department of Health and Human Services to draw up new regulations making employee vaccination a condition for nursing homes to participate in Medicare and Medicaid, a move that represents a significant escalation in the White House’s campaign to get Americans vaccinated and the tools he is willing to use, marking the first time he has threatened to withhold federal funds in order to get people vaccinated. A Covid-19 vaccine for children is an extraordinarily high priority for the Biden administration and the US Food and Drug Administration will evaluate the data quickly once it is provided by the companies that make them, US Surgeon General Dr. Vivek Murthy said Wednesday, adding that “The timeline really depends on how quickly the companies are able to do the trials and get that data to the FDA.” President Biden criticized governors today who are "trying to block and intimidate local school officials and educators" over the use of masks in schools, calling the actions "wrong" and "unacceptable," and announced that he is directing Education Secretary Miguel Cardona to use "all of his oversight authorities and legal action, if appropriate, against governors who are trying to block and intimidate local school officials and educators," as they attempt to combat the spread of Covid-19.
Load more

Recommended publications
  • COVID-19 Vaccination Programme: Information for Healthcare Practitioners
    COVID-19 vaccination programme Information for healthcare practitioners Republished 6 August 2021 Version 3.10 1 COVID-19 vaccination programme: Information for healthcare practitioners Document information This document was originally published provisionally, ahead of authorisation of any COVID-19 vaccine in the UK, to provide information to those involved in the COVID-19 national vaccination programme before it began in December 2020. Following authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency being given to the COVID-19 Vaccine Pfizer BioNTech on 2 December 2020, the COVID-19 Vaccine AstraZeneca on 30 December 2020 and the COVID-19 Vaccine Moderna on 8 January 2021, this document has been updated to provide specific information about the storage and preparation of these vaccines. Information about any other COVID-19 vaccines which are given regulatory approval will be added when this occurs. The information in this document was correct at time of publication. As COVID-19 is an evolving disease, much is still being learned about both the disease and the vaccines which have been developed to prevent it. For this reason, some information may change. Updates will be made to this document as new information becomes available. Please use the online version to ensure you are accessing the latest version. 2 COVID-19 vaccination programme: Information for healthcare practitioners Document revision information Version Details Date number 1.0 Document created 27 November 2020 2.0 Vaccine specific information about the COVID-19 mRNA 4 Vaccine BNT162b2 (Pfizer BioNTech) added December 2020 2.1 1.
    [Show full text]
  • Monday, September 14, 2020 Home-Delivered $1.90, Retail $2.20 Tears Flow
    Nupepa o Te Tairawhiti THE GISBORNE HERALD RĀHINA, MAHURU 9, 2019 I MONDAY, SEPTEMBER 9, 2019 HOME-DELIVERED $1.70, RETAIL $2.00 TE NUPEPA O TE TAIRAWHITI RAHINA, MAHURU 14, 2020 I MONDAY, SEPTEMBER 14, 2020 HOME-DELIVERED $1.90, RETAIL $2.20 TEARS FLOW AT C COMPANY HOUSE PAGE 3 PUKANA: Kereru class students at Te TOLAGA BAY CIVIL DEFENCE PAGE 4 ‘All day, every day, te reo is our way’ Hapara School practise their te reo Maori every day. Te Wiki o te reo Maori VOLUNTEERS RECOGNISED is another week where the students UNHEARDOFSAVINGS! IT is Te Wiki o te reo Maori Ms Neilson said. what they teach us every embrace te ao Maori. The children are (Maori Language Week) but “Singing connects us morning so we will become pictured with teacher Tanya Neilson. te reo Maori is used at Te and brings us together better performers, therefore Picture by Liam Clayton. Hapara School every school and creates memories and incorporating the intrinsic day. memory space in our brains. link to culture and identity PAGES Each day the kereru “We know our students and the essential element 5-8,11, whanau class have the enjoy our morning sessions of whanaungatanga (the 12, 13, 16 same routine of performing and they could independently importance of people and a waiata (song), karakia run it on their own. connectedness),” said Ms (prayer) and haka and “We are a culturally diverse Neilson. HEARING• Mask refusal halts Fullers ferry trip practise use of te reo Maori whanau and celebrate and “The school’s focus this •NEW Political party leader’s Covid theories kupu (words) and commands respect all people.” year has been about creating raising fears for Maori health because that is a part of who Te Hapara has two kapa a sense of belonging and PBL they are as a class, says haka tutors — Papa Pura and we feel that through culture, • Expecting ugly GDP figures for quarter teacher Tanya Neilson.
    [Show full text]
  • Safe Return Plan FINAL
    Safe Return to In-Person Instruction and Continuity of Service Pursuant to the Federal American Rescue Plan Act Hazlet Township School District June 2021 Revision: August 2021 HAZLET TOWNSHIP PUBLIC SCHOOLS ADMINISTRATION 2021-2022 BOARD OF EDUCATION Board President Victor J. Iannello, Jr. Vice President Jodie Moreno Board Members David Asfour Edward Barrett John Granite Steven Grossman William Kolibas Laura O’Hara George Theis Student Member James Grebenstein CENTRAL OFFICE ADMINISTRATION Superintendent of Schools Scott Ridley, Ed.D. Assistant Superintendent of Schools Joseph J. Annibale School Business Administrator/Board Secretary Christopher J. Mullins DIRECTORS Director of Curriculum, Instruction & Testing Heather Schwarz Director of Special Services Jacqueline Hafner Director of School Counseling Services Julie Ciccarone Director of Athletics John DeGenito SUPERVISORS Supervisor of Language Arts Suzanne Capraro Supervisor of Mathematics Jennifer Martins Supervisor of Science Michael Miller Supervisor of Special Services Chantal Molino Supervisor of Buildings & Grounds Charles Hildner Network Administrator Joseph Emerson District Affirmative Action Officer Andrew Piotrowski, Ed.D. Title IX Coordinator Suzanne Capraro BUILDING PRINCIPALS Sycamore Drive ECLC Gina Dorozynski Lillian Drive School Kathleen Matsutani Middle Road School Katherine Egan Raritan Valley School John Verderosa Beers Street School Ian Collis Cove Road School Dara Van Pelt Hazlet Middle School Christine McCoid, Ed.D. Raritan High School Andrew Piotrowski, Ed.D. Hazlet Township School District Date: June 15, 2021 Revised: August, 2021 1. Maintaining Health and Safety For each mitigation strategy listed below (A–H), please describe how the LEA will maintain the health and safety of students, educators, and other staff and the extent to which it has adopted policies, and a description of any such policies, on each of the following safety recommendations established by the CDC.
    [Show full text]
  • COVID-19 Vaccines BJC and WUSM Employees
    COVID-19 vaccines BJC and WUSM employees FAQs – updated September 10, 2021 Updates to this document have been made in red. The content in this document is intended for BJC/Washington University School of Medicine (WUSM) employees only, not for the general public. Click the topic below to go directly to the section: • Vaccine requirement and distribution – BJC/WUSM employees and contingent workers • Vaccine safety • Vaccine effectiveness • Vaccine distribution - public • Questions prior to receiving the vaccine • After I get the vaccine • More about the vaccines Vaccine requirement and distribution – BJC/WUSM employees and contingent workers 1. Which vaccine was officially approved by the FDA, and how is this different than the emergency use authorization the FDA granted the vaccine previously? On August 23, 2021, the Pfizer COVID-19 vaccine officially received full FDA approval. It is the first COVID-19 vaccine to receive this approval. This action by the FDA may influence some unvaccinated citizens to get vaccinated, as it is additional validation that the vaccine is safe and effective in preventing severe COVID-19 infection. For BJC, the FDA action does not change our requirement that all team members be vaccinated. 2. What is the deadline for employees to be vaccinated? September 15 is now the deadline for receiving a dose of any COVID-19 vaccine: first doses of a two-dose series or the single-dose Johnson & Johnson/Janssen vaccine. At this point, employees with a single dose of a two-dose vaccine will be “conditionally compliant” with the expectation 1 COVID-19 vaccine rollout to BJC and WUSM employees FAQs CS_586771 6/24/21 that they complete the series within 30 days.
    [Show full text]
  • Negative Attitudes About Facemasks During the COVID-19 Pandemic
    medRxiv preprint doi: https://doi.org/10.1101/2020.11.17.20233585; this version posted November 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. 1 1 2 Running head: Negative attitudes about facemasks 3 4 5 Negative attitudes about facemasks during the COVID-19 pandemic: The dual importance of 6 perceived ineffectiveness and psychological reactance 7 Steven Taylor1 and Gordon J. G. Asmundson2 8 1Department of Psychiatry, University of British Columbia, Vancouver, BC, CANADA 9 2Department of Psychology, University of Regina, Regina, SK, CANADA 10 11 12 Correspondence: Steven Taylor, PhD, Department of Psychiatry, University of British Columbia, 13 Vancouver, Canada, V6E 2A1. E-mail: [email protected]. 14 15 Acknowledgements: The authors thank Michelle M. Paluszek, Caeleigh A. Landry, and Geoffrey 16 S. Rachor for their assistance in completing this study. 17 18 19 20 21 22 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.11.17.20233585; this version posted November 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. 2 23 Abstract 24 This study reports a comprehensive empirical investigation of the nature and correlates of anti- 25 mask attitudes during the COVID-19 pandemic.
    [Show full text]
  • The Political Economy of Covid-19 Vaccines
    TIF - The Political Economy of Covid-19 Vaccines JAYATI GHOSH March 5, 2021 Elderly waiting in line for their shots at a mass vaccination drive at Ecatepec town of Mexico (22 February) | Jose M. Ruiz/Eyepix/abacapress.com Vaccine grabs, the refusal to relax patents to enable mass production, and the use of vaccines for diplomacy run the risk that poorer nations may not be protected against Covid-19 quickly enough. This will prolong the pandemic, even for the richer nations. The Covid-19 pandemic has been unusual in several ways: the disproportionate extent to which people in rich countries (particularly in Europe and North America) have been affected; the sheer scale of the policy response for containment; and the speed and urgency of the global response. The active interest in controlling the pandemic in rich countries shaped individual national responses as well as global policy. There was a massive push for vaccine development, through large subsidies for research and development to drug companies, pre-orders of vaccines, and other support by the US, Russia, China, and European countries. Page 1 www.TheIndiaForum.in March 5, 2021 The production and distribution of Covid-19 vaccines has exposed and intensified global inequality. This led to the rapid development of multiple Covid-19 vaccine candidates and even more rapid regulatory approval to several of them. Typically, vaccines take several years to be developed and approved, partly because of extended clinical trials to check for all possible responses. But some Covid-19 vaccine candidates were given official approval in Russia and China even before the essential Phase III trials were completed.
    [Show full text]
  • IN the SUPREME COURT of INDIA CIVIL ORIGINAL JURISDICTION Suo Motu Writ Petition (Civil) No.3 of 2021 in RE: DISTRIBUTION of ES
    Reportable IN THE SUPREME COURT OF INDIA CIVIL ORIGINAL JURISDICTION Suo Motu Writ Petition (Civil) No.3 of 2021 IN RE: DISTRIBUTION OF ESSENTIAL SUPPLIES AND SERVICES DURING PANDEMIC. 1 O R D E R This order has been divided into the following sections to facilitate analysis: A Introduction B Outline of the Disaster Management Act C Medical Infrastructure C.1 Submissions in UOI’s Affidavits C.2 National Policy for Admission in Hospitals D Oxygen allocation and availability E Vaccines E.1 Vaccine capacity and disbursal E.2 Vaccine pricing F Potentiality of Compulsory Licensing for vaccines and essential drugs G Supply of Essential Drugs G.1 Submissions in the Central Government’s Affidavits G.2 Recommendations G.3 Black Marketing H Recommendations for augmenting healthcare workforce I Epilogue J Conclusion 2 PART A A Introduction 1 The genesis of this suo motu writ petition is in an order dated 22 April 2021. This Court took note of the unprecedented humanitarian crisis in the country, following the outbreak of the COVID-19 pandemic. Notices were issued to the Union of India1, the Governments of the States and Union Territories2, and to several petitioners who were before the High Courts. The Court observed: “the Union Government, the State Governments/Union Territories and the parties, who appeared to have approached the High Courts to show cause why uniform orders be not passed by this Court in relation to a) Supply of oxygen; b) Supply of essential drugs; c) Method and manner of vaccination; and d) Declaration of lockdown” The Court directed the Central Government to : “1.
    [Show full text]
  • COVID-19 Vaccines: Frequently Asked Questions
    COVID-19 vaccines: Frequently asked questions The following information concerns the storage, handling and use of COVID-19 vaccines from the following manufacturers: • Moderna • Pfizer/BioNTech • University of Oxford/AstraZeneca These vaccines have been included because they have received emergency use authorisations/ approvals and phase III clinical trial data are available about their safety and efficacy. This document was published on 28 January 2021. As other COVID-19 vaccines become widely used, receive national approvals and possess phase III clinical trial data, they will be added to this document. 1. How do the different vaccines work, i.e., mRNA vaccines vs viral-vector? Category Developer Mechanism Nucleic acid Moderna A person receives genetic material — mRNA — that vaccines Pfizer/BioNTech encodes the viral protein. When these genetic (proteins that instructions are injected the muscle cells translate them direct to make the viral protein directly in the body. This gives production of the immune system a preview of what the real virus other proteins): looks like without causing disease. This preview gives mRNA or DNA the immune system time to design powerful antibodies that can neutralise the real virus if the individual is ever infected. For information about how mRNA vaccines work see: https://theconversation.com/how-mrna-vaccines-from- pfizer-and-moderna-work-why-theyre-a-breakthrough- and-why-they-need-to-be-kept-so-cold-150238 https://www.cdc.gov/vaccines/covid-19/hcp/mrna- vaccine-basics.html Further information on safety and efficacy: Polack FP, Thomas SJ, Kitchin N, et al, for the C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.
    [Show full text]
  • Assessing the Level and Determinants of COVID-19 Vaccine Confidence In
    medRxiv preprint doi: https://doi.org/10.1101/2021.06.11.21258775; this version posted June 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Assessing the level and determinants of COVID-19 Vaccine Confidence in Kenya Stacey Orangi 1,2*, Jessie Pinchoff3, Daniel Mwanga4, Timothy Abuya4, Mainga Hamaluba5,6, George Warimwe5,6, Karen Austrian4, Edwine Barasa1,6 Authors’ affiliation 1 Health Economics Research Unit (HERU), KEMRI-Wellcome Trust Research Program, Nairobi, Kenya 2 Institute of Healthcare Management, Strathmore University, Nairobi, Kenya 3 Population Council, New York, USA 4 Population Council, Nairobi, Kenya 5 KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya 6 Nuffield Department of Medicine, Oxford University, UK *Corresponding author: [email protected] ABSTRACT The government of Kenya has launched a phased rollout of COVID-19 vaccination. A major barrier is vaccine hesitancy; the refusal or delay of accepting vaccination. This study evaluated the level and determinants of vaccine hesitancy in Kenya. We conducted a cross-sectional study administered through a phone-based survey in February 2021 in four counties of Kenya. Multivariate logistic regression was used to identify individual perceived risks and influences, context-specific factors, and vaccine-specific issues associated with COVID-19 vaccine hesitancy. COVID-19 vaccine hesitancy in Kenya was high: 60.1%. Factors associated with vaccine hesitancy included: older age, lower education level, perceived difficulty in adhering to government regulations on COVID-19 prevention, less adherence to wearing of face masks, not having ever been tested for COVID-19, no reported socio- economic loss as a result of COVID public-health restriction measures, and concerns regarding vaccine safety and effectiveness.
    [Show full text]
  • Efforts at COVID-19 Vaccine Development
    Review Efforts at COVID-19 Vaccine Development: Challenges and Successes Azizul Haque 1,* and Anudeep B. Pant 2 1 One Medical Center Drive, Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA 2 New Orleans East Hospital, 5620 Read Blvd, New Orleans, LA 70127, USA; [email protected] * Correspondence: [email protected] Received: 23 November 2020; Accepted: 3 December 2020; Published: 6 December 2020 Abstract: The rapid spread of SARS-CoV-2, the new coronavirus (CoV), throughout the globe poses a daunting public health emergency. Different preventive efforts have been undertaken in response to this global health predicament; amongst them, vaccine development is at the forefront. Several sophisticated designs have been applied to create a vaccine against SARS-CoV-2, and 44 candidates have already entered clinical trials. At present, it is unclear which ones will meet the objectives of efficiency and safety, though several vaccines are gearing up to obtain emergency approval in the U.S. and Europe. This manuscript discusses the advantages and disadvantages of various vaccine platforms and evaluates the safety and efficacy of vaccines in advance stages. Once a vaccine is developed, the next challenge will be acquisition, deployment, and uptake. The present manuscript describes these challenges in detail and proposes solutions to the vast array of translational challenges. It is evident from the epidemiology of SARS-CoV-2 that the virus will remain a threat to everybody as long as the virus is still circulating in a few. We need affordable vaccines that are produced in sufficient quantity for use in every corner of the world.
    [Show full text]
  • Face Covering Obstinacy: Ideology Unmasked
    Open Access Journal of Community Medicine & Health Care Mini Review Face Covering Obstinacy: Ideology Unmasked DeBoy JL* and Monsilovich SB Department of Health Sciences, Lincoln University, New Abstract Zealand Despite myriad public health guidelines strongly encouraging use of face *Corresponding author: James L DeBoy, Department coverings and select government entities requiring face mask use during the of Health Sciences, Lincoln University, New Zealand COVID-19 viral pandemic, many Americans vehemently protest and resist the community call for compliance. While the current social-political climate Received: October 13, 2020; Accepted: November 03, of perceived government overreach plays a major role in mask refusal, there 2020; Published: November 10, 2020 are other factors. This paper will explore those motivations that undergird this dangerous behavior that threatens not just the welfare of the non-user but also the health of the larger community. Keywords: COVID-19; Face masks; Public health guidelines Introduction conflicting public health edicts caused a number of local public health officials to ignore the CDC agency and follow their own judgments In the past seven months much has been written about the (Vestal & Ollove, 2020). An unfortunate result of eroding trust in COVID-19 pandemic and its debilitating effect upon the nation’s the CDC confuses and possibly leads the general public to disregard health and economic statuses. While the entire world awaits guidance that could save lives. the arrival of an effective vaccine, the three most widely-touted proactive measures designed to contain the virus’ spread consist of The published data on COVID-19’s morbidity and mortality rates sheltering in-place, social distancing, and wearing of face coverings.
    [Show full text]
  • Covid-19 Under Democracy and Autocracy
    © Rutgers, The State University of New Jersey (New Brunswick) This publication is the work of the Spring 2021 Capstone class of the United Nations and Global Policy Studies Master of Arts program (UNMA), Political Science Department, Rutgers University (New Brunswick) June 2021 Application for permission to reproduce or translate all or any part of this publication should be made to: UNMA Secretariat Hickman Hall 89 George Street New Brunswick, NJ 08901 Email: [email protected] Title: Covid-19 Under Democracy and Autocracy Editor: Dr. Roland Rich Cover Design: Ian DeFalco Layout: Camilla Bober ISBN 978-0-578-92527-1 CONTENTS Contributors 1 Chapter 1 A Project is Born 4 Roland Rich Chapter 2 Australia’s Covid-19 Response: 10 The Achilles Heel Shahinaz Abdelhamid Chapter 3 Brazil: Negligence and Populism during 34 a Global Health Crisis Gabriela Casco Chapter 4 Cuba’s Vaunted Medical System Faces Covid-19 54 Javier Nino Chapter 5 Federalism, the EU, and Human Rights 68 in Germany under COVID-19 Camilla Bober Chapter 6 Russia: A Contest between Science and Denial 94 Amar Wason Chapter 7 South Africa Faces Covid-19 116 Delaney Charydczak Chapter 8 Taiwan: A Near Perfect Response 128 to the Coronavirus Pandemic Ryan Prieto Chapter 9 The Impact of Covid-19 on Elections 148 in Uganda Susan Ombwayo Chapter 10 The United Kingdom: Covid-19 162 and the Decay of Democracy Arsanious Hanna Chapter 11 Vietnam: Looking beyond Regime Type 182 Daphnée A.M. Fleurant Chapter 12 Conclusions, Constatations and Concerns 196 Roland Rich Bibliography 224 1 CONTRIBUTORS Shahinaz Abdelhamid received her B.S.
    [Show full text]